Company Filing History:
Years Active: 2014
Title: Axel Steffen Erler: Innovator in Nucleic Acid Recombination
Introduction
Axel Steffen Erler is a notable inventor based in Haselbach, Germany. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid recombination. His innovative methods have the potential to advance genetic research and applications.
Latest Patents
Erler holds a patent for a method of nucleic acid recombination. This invention provides a method for inserting a single stranded replacement nucleic acid into a target nucleic acid. The process involves generating a single stranded replacement nucleic acid from a double stranded nucleic acid, exposing the target nucleic acid to the replacement nucleic acid, and selecting a target nucleic acid whose sequence has been altered. This method opens new avenues for genetic modification and research.
Career Highlights
Erler is associated with Gene Bridges GmbH, a company that focuses on innovative solutions in genetic engineering. His work at Gene Bridges has allowed him to explore and develop advanced techniques in nucleic acid manipulation. With a patent portfolio that includes 1 patent, he continues to contribute to the scientific community.
Collaborations
Erler has collaborated with notable colleagues such as Marcello Maresca and Jun Fu. These partnerships have fostered a collaborative environment that enhances research and innovation in their field.
Conclusion
Axel Steffen Erler's contributions to nucleic acid recombination exemplify the impact of innovative thinking in biotechnology. His work not only advances scientific understanding but also paves the way for future developments in genetic engineering.